Tokyo, March 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061092) titled 'Impact of Heparin Calcium Supply Discontinuation on Deep Vein Thrombosis I... Read More
Tokyo, March 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061094) titled 'A Study on Improving Oral Care Knowledge Among Nurses at Hospital A Throug... Read More
Tokyo, March 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061093) titled 'A study of surgical treatment as conversion therapy for initially unresect... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airwa... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safe... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of L... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'CO45042: A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Divarasi... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Du... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-la... Read More
Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safe... Read More